BBIO
BridgeBio Pharma Inc
67.00$
+1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -48.3% | +0.0% | -100.0% | – | -98.5% | +278.7% | +11,593.5% | -95.7% | +449.7% | -86.9% | +4,253.4% | -99.5% | +453.3% | -2.4% | -10.1% | +149.3% | -57.3% | +11,998.6% | -99.0% | +26.0% | +115.3% | +1,882.9% | -5.2% | +9.2% | +27.7% | +26.2% | +14.4% | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | +1,233.9% | +6.7% | -13.1% | -48.1% | +5.6% | -12.4% | +0.6% | -8.0% | -0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +248.5% | +26.6% | +38.4% | +79.7% | +134.9% | -32.4% | +44.3% | – | |
| – | – | – | – | – | – | – | -43.0% | +0.0% | – | – | -98.5% | +278.7% | +11,569.9% | -98.3% | +1,173.6% | -96.9% | +21,011.6% | -100.5% | – | -3.9% | -11.3% | +235.2% | -67.2% | +18,254.1% | -99.3% | +35.9% | +78.0% | +2,901.4% | -6.2% | +6.8% | +21.6% | +32.7% | +12.7% | – | |
| – | -29.4% | +30.4% | +64.4% | -12.4% | +16.7% | +5.6% | +4.0% | +18.7% | +26.9% | +6.3% | -2.0% | +35.9% | -16.8% | +2.3% | +17.2% | -11.9% | +0.7% | -14.7% | -1.7% | +2.2% | +15.8% | +16.4% | +4.1% | +8.3% | -18.6% | +5.0% | +8.2% | -14.5% | -0.2% | +1.5% | +25.8% | -10.8% | +18.0% | – | |
| – | +36.0% | -5.4% | +39.5% | +31.4% | -10.1% | +38.3% | +48.8% | -2.0% | +10.8% | -5.1% | +3.9% | +21.3% | +1.2% | +0.2% | -1.5% | -3.7% | -16.7% | -14.4% | +2.2% | -2.4% | +16.1% | -1.0% | +33.0% | +38.3% | -9.5% | +15.6% | +37.7% | +12.2% | +21.4% | +6.6% | +14.9% | +3.7% | +13.6% | – | |
| – | -16.9% | +19.2% | +58.2% | -2.8% | +8.7% | +13.6% | +17.4% | +10.8% | +21.5% | +2.8% | -0.4% | +31.6% | -11.9% | +1.7% | +17.7% | -1.7% | -12.0% | -16.0% | +1.4% | -2.4% | +15.6% | +9.5% | +10.8% | +17.7% | -15.7% | +9.5% | +18.5% | -5.0% | +10.5% | +7.5% | +24.9% | -10.5% | +8.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -51,277.6% | – | – | – | – | – | – | – | – | – | |
| – | +2,828.6% | +463.9% | +2.0% | +41.7% | +16.2% | +8.9% | +43.9% | +31.9% | +168.2% | +1.6% | +0.3% | -11.2% | +11.3% | +2.1% | +36.7% | +34.4% | -0.3% | -2.2% | +0.8% | +0.7% | +2.4% | -1.4% | -0.2% | +15.8% | -2.3% | +0.5% | +29.3% | +41.3% | -10.7% | -68.8% | +2.2% | +340.1% | -74.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -158.7% | – | – | – | -82.0% | -34.9% | +8.6% | +185.4% | +199.9% | -236.5% | – | +87.3% | +121.5% | -43.5% | -108.5% | – | -105.1% | – | – | – | +89.6% | -3.9% | -173.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -715.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.